Control (n = 45) | 3 μM Dib (n = 9) | 10 μM CP (n = 12) | 30 μM CP (n = 11) | 100 μM CP (n = 5) | 3 μM Dib and 30 μM CP (n = 11) | |
---|---|---|---|---|---|---|
RMP, mV | −62.5 ± 3.0 | −59.7 ± 3.0 | −62.4 ± 3.2 | −65.6 ± 3.1 | −64.0 ± 2.6 | −63.5 ± 3.7 |
fAHP, mV | −3.4 ± 1.9 | −2.7 ± 1.7 | Absent* (11/12) | Absent* | Absent* | Absent* |
AP threshold, mV | −47.5 ± 4.4 | −46.0 ± 3.8 | −47.7 ± 2.7 | −49.1 ± 2.8 | −47.0 ± 3.4 | −38.8 ± 4.6† |
AP freq (0.1 nA), Hz | 12.7 ± 9.5 | 12.3 ± 9.5 | 6.8 ± 4.4 * | 6.0 ± 2.1* | 1.2 ± 1.3† | 0.5 ± 0.8† |
AP freq (0.2 nA), Hz | 24.3 ± 9.5 | 34.2 ± 16.4 | 13.2 ± 4.2† | 9.4 ± 2.5† | 1.6 ± 0.9† | 2.3 ± 1.8† |
AP freq (0.3 nA), Hz | 31.5 ± 8.7 | N/A | 16.8 ± 5.1† | 11.4 ± 2.8† | 2.2 ± 1.1† | 2.9 ± 2.3† |
AP ampl, mV | 89.6 ± 10.0 | 70 ± 21.5* | 82.3 ± 14.4 | 74.9 ± 15.4* | 62.5 ± 15.0† | 70.5 ± 10.2* |
AP dur (½ ampl), ms | 1.0 ± 0.1 | 1.0 ± 0.2 | 1.0 ± 0.1 | 1.4 ± 0.9* | 2.0 ± 2.6† | 1.3 ± 0.2* |
Rin, MΩ | 47.4 ± 8.4 | 46.6 ± 1.7 | 45.8 ± 6.3 | 66.8 ± 17.2* | 80.9 ± 16.9† | 57.5 ± 11.5* |
Article: Examining protection from anoxic depolarization by the drugs dibucaine and carbetapentane using whole-cell recording from CA1 neurons.
Full Text (publisher's website) ; Article Metadata ; Article Data (extracted) None J. Neurophysiol., 2012